MRI与CT在介入治疗肝癌后癌肿残留及复发早期诊断中的应用价值

The Application Value of MRI and CT in the Early Diagnosis of Cancer Residual and Recurrence after Interventional Therapy of Liver Cancer

目的:浅析肝癌介入治疗后癌肿残留及复发早期诊断中MRI与CT的应用价值.方法:筛选2018年1-12月于笔者所在医院行介入治疗的91例肝癌患者为研究对象,均进行MRI检查和CT检查,对比诊断结果.结果:MRI对癌肿残留及复发诊断准确度为98.41%,高于CT的77.78%,差异有统计学意义(P<0.05).MRI有包膜病灶检出率为17.74%,高于CT的5.44%,差异有统计学意义(P<0.05).结论:在肝癌介入治疗后癌肿残留及复发的早期诊断中,MRI和CT均有较高的应用价值,但MRI的准确度更高,是首选的诊断方法,值得推广应用.

Objective:To analyze the application value of MRI and CT in the early diagnosis of cancer residual and recurrence after interventional therapy of liver cancer.Method:Screened of 91 patients with liver cancer who underwent interventional therapy in our hospital from January to December 2018 were studied.All patients underwent MRI and CT examinations,and the diagnosis results were compared.Result:The diagnostic accuracy of cancer residual and recurrence in MRI was 98.41%,which was higher than 77.78%of CT,and the difference was statistically significant(P<0.05).The detection rate of enveloped lesions in MRI was 17.74%,which was higher than 5.44%of CT,and the difference was statistically significant(P<0.05).Conclusion:MRI and CT have high application value in the early diagnosis of cancer residual and recurrence after interventional therapy of liver cancer.However,MRI has higher accuracy,and it is the preferred diagnostic method and worthy of popularization and application.